observational – Page 2

New tool to measure outcomes in Huntington’s Disease clinical trials

A better tool for HD trials! New research shows innovative way to measure mutant Huntingtin outside the brain

By Megan Krench

September 3, 2015

Does an ‘intermediate’ CAG repeat count in the Huntington’s disease gene cause brain changes?

August 19, 2013

Final results from the TRACK-HD study show very specific changes in HD. We're ready for trials: bring on the drugs!

May 9, 2013

Final day of our coverage of the Huntington's Disease Therapeutics Conference 2013

April 11, 2013

Levels of the huntingtin protein can be directly measured in blood – could this be useful for gene silencing studies?

November 6, 2012

Watch the full video of EuroBuzz day 1 with Jeff Carroll and Ed Wild at the Euro-HD Network Meeting in Stockholm

September 19, 2012

EuroBuzz news: Day 3. Ed and Jeff reporting from the European Huntington’s Disease Network 2012 meeting in Stockholm

September 16, 2012

HD patients are less likely to get cancer, according to a study from Sweden – what does this mean?

April 25, 2012

More reasons to be active: a passive lifestyle may contribute to earlier onset of symptoms in HD.

January 10, 2011

Smaller total brain volumes in male HD mutation carriers suggests brain development may be different in HD.

December 6, 2010